Beauty brand L'Oréal USA is leveraging Clarabridge, a provider of sentiment and text analytics for customer experience management, to monitor what is being said in real time about its 27 brands across social media outlets, including website reviews, product reviews, blogs, Twitter and Facebook.
Apparently less is more when it comes to mouthwash. According to SymphonyIRI Group data, the mouthwash segment has essentially been flat for the 12 weeks ended June 10, yet there proved to be one shining star in the mix: Listerine Zero.
A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.
The Walgreens Health Guide has a pharmacy technician license and at least two years in medical training. While there is a station positioned in front of the pharmacy, the Health Guides more often are in the aisles helping patients rather than waiting for patients to come to them.
Why is the news that CVS Caremark Charitable Trust has teamed up with the National Association of Community Health Centers important? $300 billion a year and an alarming rise in the number of Americans suffering from chronic diseases. That’s why.
Prepare to roll up your sleeves, because the battle for the ESI patient has only just begun. While Wall Street is busy calculating the earnings-per-share impact this will have on all relevant parties (at press time, Walgreens’ shares had consistently hovered around the $35 range, up almost $4 in the week following the announcement), the business of pharmacy retailing will return to block and tackle mode.
Shoppers still are purchasing on impulse at the front end of the store. Data from SymphonyIRI Group indicated that more than half of consumers make unplanned purchases upon seeing products or deals in the store — a percentage that has remained unchanged during the past 18 months.
How can Congress plug the leaks in the pharmaceutical supply chain and dry up the stream of gray market drugs without making the current drug shortage even worse? And can federal regulators shut down gray market profiteers without limiting “the ability of pharmacies to take care of their patients?”